Now showing items 1-1 of 1

    • The Impact of COVID-19 on Access to Parkinson's Disease Medication. 

      Cheong, JL-Y; Goh, ZHK; Marras, C; Tanner, CM; Kasten, M; Noyce, AJ; Movement Disorders Society Epidemiology Study Group (2020-08-28)
      BACKGROUND: Many countries have implemented drastic measures to fight the COVID-19 pandemic. Restrictions and diversion of resources may have negatively affected patients with Parkinson's disease (PD). Our aim was to examine ...